CLARITEV CORP
CTEVNYSETrading Snapshot
- Day Range
- $21.40 β $21.97
- 52-Week Range
- $11.50 β $73.68
- Volume
- $3.00B
- Avg Volume
- $3.84B
- Shares Outstanding
- 17.0M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $965M
- Last Q Revenue
- $257M
- P/E Ratio
- -1.3
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-16.69
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.8%
Why Investors Own CTEV
- βHigh-growth profile β revenue up +45.1% YoY with expanding US Equity exposure.
- βHealthy economics β 55% gross margin and 13% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CLARITEV CORP
CTEVAbout CLARITEV CORP
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologiesβincluding descriptive, predictive, and prescriptive analyticsβto refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Claritev (NYSE:CTEV) CFO Douglas Michael Garis Sells 9,025 Shares
Claritev (NYSE: CTEV - Get Free Report) CFO Douglas Garis sold 9,025 shares of the firm's stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $30.59, for a total tran

Claritev Selected by GDIT to Support CDC's World Trade Center Health Program
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #GDIT--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been se

Claritev (NYSE:CTEV) Receives Consensus Rating of βModerate Buyβ from Brokerages
Claritev (NYSE: CTEV - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a s

Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100
On September 17, 2026, Claritev Corp (CTEV) shares fell 5.5%, bringing the current price to $31.73. The stock has experienced a significant decline, with a rang

Claritev Releases 2025 Corporate Responsibility Report
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CommunityImpact--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 C

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript